Australia appears to be experience innovative medication for excess weight: Retatrutide. This new dual molecule – targeting on both GLP-1 and GIP receptors – shows promising results in clinical studies, suggesting substantial reductions in BMI. While approval hasn't occurred with Australian regulators, many individuals battling obesity might vi